Home Home
Skip to content
  • Capabilities
  • People
  • Insights
  • Locations
  • Careers
Home
  • Capabilities
  • People
  • Insights
  • Locations
  • Careers
  • Who we are
  • Responsible business
  • News
  • HSF Kramer Notes
  • Alumni
  • Events
  • Contact us

Follow us

Home
  • Who we are
  • Responsible business
  • News
  • HSF Kramer Notes
  • Alumni
  • Events
  • Contact us

Follow us

  • All
  • Capabilities
  • People
  • Insights
  • Notes
  • Locations
  • News
  1. HSF Kramer home /
  2. HSF Kramer Notes /
  3. Intellectual Property Notes /
  4. Intellectual Property Notes: Tag listing
Print page
Share
  • Share to Facebook
  • Share to Twitter
  • Share to LinkedIn
  • Email

Intellectual Property Notes

Intellectual Property Notes
  • Home
  • Events
  • Our team
  • Practice news
  • UPC insights
Subscribe

Tag: pharmaceuticals

Showing 5 out of 5 results

09 December 2025

Preserving the status quo: Boehringer Ingelheim awarded interim injunction

Preserving the status quo: Boehringer Ingelheim awarded interim injunction
06 December 2023

Competition law and biosimilars: Time for a new approach or not yet?

Competition law and biosimilars: Time for a new approach or not yet?
19 October 2023

It all comes back to construction - long-awaited judgement in UK High Court mirabegron case

It all comes back to construction - long-awaited judgement in UK High Court mirabegron case
23 March 2021

Judicial review - another weapon in Big Pharma's disputes arsenal?

Judicial review - another weapon in Big Pharma's disputes arsenal?
26 November 2020

The European Commission considers the future of health in Europe with new Pharmaceutical Strategy and Action Plan on IP

The European Commission considers the future of health in Europe with new Pharmaceutical Strategy and Action Plan on IP

Essential information

  • News
  • Who we are
  • Alumni
  • Contact us
  • Pro bono legal
  • Inclusion
  • Responsible business

Follow us


© Herbert Smith Freehills Kramer LLP 2026
  • Modern slavery and human trafficking statement
  • Site map
  • Accessibility
  • Legal and regulatory
  • Privacy policy
  • Report fraud